Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Website Tools
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +


NIAID has made groundbreaking contributions to the field of hepatitis research. NIAID scientists discovered the hepatitis A and E viruses; developed one of the first diagnostic tests for hepatitis A; and were instrumental in the creation of the hepatitis A vaccine, which is recommended by the Centers for Disease Control and Prevention of all children over 1 year old. Today, NIAID continues its leadership by conducting and supporting research to better understand the development of hepatitis diseases and their effect on the immune system and to develop novel treatments and vaccines against diseases caused by hepatitis viruses.

View Slides

What's New

The Path to a Cure for Hepatitis C in People with HIV—July 27, 2015

NIH-Led Study to Assess Community-Based Hepatitis C Treatment in Washington, D.C.—March 6, 2015

Media Availability: High Hepatitis C Cure Rate Seen in NIH-Led Trial of Six-Week Oral Drug Regimens—Jan. 12, 2015

NIH Study Describes Burden of Hepatitis C in India—Dec. 4, 2014

All Hepatitis News Releases


Last Updated July 27, 2015